BioGend Therapeutics Co., Ltd. (TPEX:6733)
Taiwan · Delayed Price · Currency is TWD 24.40
+0.20 (0.83%)
Oct 16, 2026, 1:09 PM CST
BioGend Therapeutics Market Cap
BioGend Therapeutics has a market cap or net worth of 3.28 billion as of October 16, 2026. It is the 25,220th most valuable company in the world and the 1,347th biggest in Taiwan. Its market cap has decreased by 40.33% in one year.
Market Cap
3.28B
Enterprise Value
2.44B
Revenue
236.58M
Global Rank
Country Rank
#1,347 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since June 18, 2019, BioGend Therapeutics's market cap has increased from 2.71B to 3.28B, an increase of 20.75%. That is a compound annual growth rate of 2.60%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 3.28B | -31.37% |
| Dec 31, 2025 | 4.78B | 14.21% |
| Dec 31, 2024 | 4.18B | -11.18% |
| Dec 29, 2023 | 4.71B | 109.50% |
| Dec 30, 2022 | 2.25B | -18.50% |
| Dec 30, 2021 | 2.76B | -22.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Formosa Pharmaceuticals | 3.82B |
| Sunhawk Vision Biotech | 3.79B |
| Pharmosa Biopharm | 3.42B |
| SYN-TECH Chem. & Pharm. | 3.39B |
| Great Novel Therapeutics Biotech & Medicals | 3.28B |
| Shine-On BioMedical | 3.14B |
| Sagittarius Life Science | 3.11B |
| Intech Biopharm | 3.09B |